22 mars: Crédit Agricole Brie Picardie : déclaration hebdo transactions su..
22 mars: ALCATEL-LUCENT : Alcatel-Lucent chargé de l'exploitation du systè..
22/03/2010 15:30:00

Next Generation Portable Water Quality Analyzer Introduced By SDIX

SDIX (Nasdaq: SDIX), a leading provider of biotechnology-based

products and services for a broad range of life science, biotech,

diagnostic, and food safety applications, today announced DeltaTox®

II, its next generation portable water quality field testing analyzer.

Designed for on-site screening at remote locations as well as for

laboratory-based water testing, the DeltaTox II analyzer replaces SDIX’s

existing DeltaTox devices, delivering test results within five minutes.

With both chemical and bio-contamination detection in one analyzer,

DeltaTox II provides rapid screening and characterization of potable

water and waste water as well as industrial and environmental water

samples.

SDIX water quality products like DeltaTox II are designed to reduce the

time and cost to test water while also providing reliable and accurate

results for informed decision making. Some customers have realized up to

50% total cost reduction versus competing alternatives.

DeltaTox II features include:

  • Fast results – rapid screening, within five minutes in the field

  • Detects both toxins and bio-contamination in one device – over 2,700

    harmful substances and chemical compounds have been documented to date

  • Improved ease-of-use – An intuitive, menu-driven user interface with

    over 50% larger backlit display screen provides more information than

    before

  • Increased reliability – No electromechanical parts, 1 year full

    warranty

  • Portable and durable – Small, rugged, lightweight (2.2 lbs) device

    made from high-strength engineering polymer, rechargeable lithium ion

    battery

SDIX water quality testing instruments are being used by over 70% of the

largest water utilities in the USA as well as wastewater treatment

facilities, industrial water treatment systems, and environmental and

eco-toxicological research organizations. These products are also

extensively used outside the U.S., in Asia, Europe and other regions

around the globe. DeltaTox II is expected to be available for sale the

second quarter of 2010. Pricing will be announced at that time.

Commenting, Michael Jones, SDIX Water Quality Market Manager, said,

“With the new DeltaTox II, customers will have more rapid, accurate,

reliable, and cost-effective results than ever, enabling them to feel

secure about their water consumption or use. Moreover, we feel it is

important to be introducing a next generation water toxicity analyzer at

a time when the global need for remote location testing is increasing

dramatically. DeltaTox II can also help us expand into new regions where

on-site testing is critical to ensure a safe water supply to the local

population.”

DeltaTox II is a member of SDIX’s family of water quality testing

products. For more information, call 800-544-8881, visit www.sdix.com

or www.sdix.com/deltatox.

About SDIX

SDIX is a biotechnology company, expert at creating advantage by

providing a broad range of quality, innovative and effective

immuno-solutions to the Pharmaceutical, Biotechnology, Diagnostics, and

Food Safety markets. For 20 years, SDIX has developed antibodies which

advance its customers’ immuno-based work – reducing time, labor, and

costs while increasing accuracy and reliability of results.

SDIX offers a full suite of integrated immuno-solution capabilities

including assay design, development, and production. In life science

markets, SDIX capabilities are being used to help discover the

mechanisms of disease, facilitate the development of new drugs, and

provide mechanisms for rapid diagnosis. For more information, visit www.sdix.com.

This news release may contain forward-looking statements reflecting

SDIX's current expectations. When used in this press release, words like

“anticipate”, “could”, “enable”, “estimate”, “intend”, “expect”,

“believe”, “potential”, “will”, “should”, “project”, “plan” and similar

expressions as they relate to SDIX are intended to identify said

forward-looking statements. Investors are cautioned that all

forward-looking statements involve risks and uncertainties, which may

cause actual results to differ from those anticipated by SDIX at this

time. Such risks and uncertainties include, without limitation, changes

in demand for products, the application of our technologies to various

uses, delays in product development, delays in market acceptance of new

products, retention of customers and employees, adequate supply of raw

materials, inability to obtain or delays in obtaining fourth party,

including AOAC, or required government approvals, the ability to meet

increased market demand, competition, protection of intellectual

property, non-infringement of intellectual property, seasonality, and

other factors more fully described in SDIX's public filings with the

U.S. Securities and Exchange Commission.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6220106&lang=en

SDIX

Michael Jones

Market Manager, Water Quality

302-456-6789

mjones@sdix.com

22 mars: Crédit Agricole Brie Picardie : déclaration hebdo transactions su..
22 mars: ALCATEL-LUCENT : Alcatel-Lucent chargé de l'exploitation du systè..

Envoyer un commentaire

Related debate

  • 1 semaine
  • 1 mois
  • 1 an
08 févr.
OMXC20
      På en dag som i dag med kursfald på +5% er det ekstra vigtigt at tænke og handle rationelt. He..
47
03 févr.
FING-B
OK Moderator - jeg bliver bare så vred, når vi, der abbonnerer på EI - gang på gang bliver provokere..
32
07 févr.
FING-B
Så drenge og piger... MENA, Swiftnick, Numers og jer er nu stolte af at kunne præsentere vores nye h..
29
05 févr.
OMXC20
  Inden jeg starter med at forklare, hvad det er der aktuelt sker på aktiemarkedet, vil jeg henvise ..
26
05 févr.
 
    En lærerinde i 3. klasse stillede sine elever det evigt relevante spørgsmål:"Hvad vil du gerne..
23
09 févr.
OMXC20CAP
Det er egentlig ganske morsomt. Men et menneskeligt træk, især blandt handyr af racen, er ofte, at m..
18
07 févr.
ZEAL
Jeg har set lidt på de patent sagerne som køre mellem AstraZeneca, Sanofi og TEVA omkring GLP-1'er. ..
15
05 févr.
NOVO-B
Købte NN i kurs 247,60 i 2014. Solgte i december 2015 i kurs 293,20. Købte Danske Bank i januar i ku..
14
05 févr.
FING-B
Vi 8 har snakket med flere analysefirmaer i dag som jeg ikke lige kan huske navnene på, og de fortæl..
14
09 févr.
OMXC20
skal man  ikke sælge - men vælge det rigtige tidspunkt at købe - om det er i dag, er svært at foruds..
13

Actualité la plus lue

  • 24 heures
  • 48 heures
  • 1 semaine
1
Coface SA Résultats 2015: un résultat net à 126 M€ et un dividende stable proposé à 0,48€ par action
2
CRCAM Alpes Provence : Mise à disposition du Rapport du Président du Conseil d'Administration au titre de la loi de sécurité financière - Exercice 2015
3
ATOS : Further expansion in the Netherlands of Bull supercomputer in 2016
4
Klépierre : RÉSULTATS ANNUELS 2015
5
Effisoft enrichit son offre globale Solvabilité II avec les « Rapports Narratifs »

Buy and sell signals

  • Tendance
  • Moneymachine
Vendre
Vendre
Vendre
Vendre

Droit d'auteur Euroinvestor A/S 2016   Mentions légales et conditions d'utilisation
Information sur les cours fournies par Interactive Data.
Les données sont différées de 15 à 20 minutes selon les accords avec les différentes bourses internationales.
 
mercredi 10 février 2016 07:36:13
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20160209.2 - EUROWEB6 - 2016-02-10 07:36:13 - 2016-02-10 07:36:13 - 4 - Website: OKAY